home Go to Doctors Page
ScienceBased Health
1 888 433 4726
  • Doctor
  • Consumer
Facebook Twitter

Free Shipping with Auto-Delivery & Savings up to 20% with a Package Plan

more +
Auto-Delivery & Free Shipping!
Save money and add convenience! Your product(s) will be automatically sent to you each month
Select the "Auto Delivery" box at checkout.
Save Packages:
Save up to 20% & Free Shipping!
Purchase 3-5 bottles: save 5%
Purchase 6-11 bottles: save 12%
Purchase 12+ bottles: save 20%

phone

Menu
  • Products
    • Products A-Z
    • Dry Eye
    • Eye & Whole Body Health
      • OcularProtect® Robust Whole Body Formula
      • OcularEssentials® Whole Body Formula
    • Macular Health Concerns
      • MacularProtect Complete® AREDS-Based Formula & Multinutrient
      • MacularProtect® AREDS-Based Formula
    • Omega-3
    • Optic Nerve Health
    • Retinal Circulation
    • Bone & Joint Health
      • BoneProtect
      • JointProtect
  • Faqs
  • Resources
    • Staying Healthy Newsletter
    • EduFacts Newsletter
    • Product Monographs
    • Educational Links
  • About us
    • Company
    • Advisory Boards
    • Press Releases
    • In the News
    • Events
  • Contact
  • Login
  • View Cart
  • (0)
Facebook Twitter

Staying Healthy Newsletter

AREDS2 Supplement Shows Benefit In Late Stage Dry AMD

AREDS2 Supplement Shows Benefit In Late Stage Dry AMD

In the news: AREDS2 Supplement Shows Benefit In Late Stage Dry AMD

Background: Stages and Forms of AMD

In the early and intermediate stages of age-related macular degeneration (AMD), the light-sensing retina at the back of the eye develops small yellow deposits of fatty proteins called drusen.

When the disease progresses to the late stage, people can develop leaky blood vessels (wet AMD) or can lose regions of light-sensitive cells in the retina (dry AMD). In dry AMD, also known as geographic atrophy, these regions slowly expand over time, causing people to progressively lose their central vision.

Remember that the AREDS trial showed that a formula containg vitamins C and E, and beta-carotene, zinc and copper slowed the progression from the intermediate to late stage AMD in people with the disease.

The later AREDS2 trial then showed that replacing beta-carotene with lutein and zeaxanthin produced a formula that was more effective and presented fewer risks.

But whether AREDS2 supplements are of any benefit to people with the late-stage of dry AMD has been an unanswered question. That’s because neither the AREDS or AREDS2 trials was able to detect any further benefit of the supplements once the participants had developed the late-stage of the disease.

AREDS2 Formula Helps Slow Late Stage AMD

Now a new analysis by the National Eye Institute-sponsored ARED and AREDS2 trial researchers suggests that AREDS2 supplements can help put the brakes on late stage dry AMD progression(1,2).

This finding is promising because the treatments for dry AMD today are only modestly effective, have important risks, and high costs.

In the study, the investigators reviewed retinal scans of participants in both trials who developd dry AMD, a total of 1,602 eyes from both studies.

They measured the position and expansion rate of the participants’ regions of geography atrophy in their eyes.

Most commonly, people with dry AMD develop leisons away from the center of the macula, the fovea which is responsible for the clearest central vision. As the disease progresses these areas of dry AMD gradually expand in toward the fovea.

The analyses showed that for the majority of people who developed geographic atrophy far away from the fovea, both the AREDS and AREDS2 supplements delayed the rate of expansion toward the fovea by 55% over an average 3 year period.

Overall, both supplements slowed the rate of expansion by 35-36% for those who had regions of geographic atrophy that had not reached the center of the macula.

They also found that the AREDS2 formula with lutein and zeaxanthin, but not the AREDS formula, also slowed the decline in visual acuity.

Neither supplement slowed degeneration in advanced cases where geographic atrophy was already in their central vision.

The authors of the study theorized that AREDS2 supplements are of benefit in late-stage AMD because they enhance a nautral phenomenon called “foveal sparing”, where dry AMD expansion into the central macula is much slower than advancement into the surrounding areas.

In the National Eye Institute’s new release, the lead study author states that “these findings support the continued use of AREDS2 supplements by people with late dry AMD.”


References

  1. Keenan TDL, et al. for the AREDS and AREDS2 Research Groups. Oral antioxidant and lutein/zeaxanthin supplements slow geographic atrophy progression to the fovea in age-related macular degeneration. Ophthalmol. July 16, 2024. https://doi.org/10.1016/j.ophtha.2024.07.014
  2. National Institutes of Health and National Eye Instiute News release. https://www.nih.gov/news July 16, 2024.
Home  >  General Webpages  >  Resources  >  Staying Healthy Newsletter Content  >  Staying Healthy Newsletter  > 

Stay Informed

Sign up to get nutrition news, health tips, and product updates.

Please also send me:
EduFacts scientific write-ups (monthly)
Notice of new products and special offers

Your information is never shared with third parties. View our privacy policy

Like Us on Facebook

Follow SBH on Facebook for great health tips, product info and much more.

Our Quality Guarantee

  • Products meet or exceed new GMPs
  • Produced in NSF®-certified facilities
  • Highest quality raw materials utilized
  • Third party testing
  • 30-day money-back guarantee (60 days for HydroEye)
Learn more »

Innovative Nutraceuticals for Eye Health

ABOUT SSL
CERTIFICATES

This site chose VeriSign SSL
for secure e-commerce and
confidential communications.

Home | Feedback | Manufacturing | Privacy Policy | Terms & Conditions | Contact Us

Call us Toll Free 1.888.433.4726. From Outside the US and Canada 281.885.7700
©ScienceBased Health

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.

Top